Allan I. Levey

106.6k total citations · 17 hit papers
507 papers, 52.1k citations indexed

About

Allan I. Levey is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Allan I. Levey has authored 507 papers receiving a total of 52.1k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Molecular Biology, 184 papers in Cellular and Molecular Neuroscience and 153 papers in Physiology. Recurrent topics in Allan I. Levey's work include Alzheimer's disease research and treatments (145 papers), Neuroscience and Neuropharmacology Research (139 papers) and Receptor Mechanisms and Signaling (97 papers). Allan I. Levey is often cited by papers focused on Alzheimer's disease research and treatments (145 papers), Neuroscience and Neuropharmacology Research (139 papers) and Receptor Mechanisms and Signaling (97 papers). Allan I. Levey collaborates with scholars based in United States, Canada and China. Allan I. Levey's co-authors include Bruce H. Wainer, Elliott J. Mufson, James J. Lah, Marla Gearing, Lee J. Martin, M.‐Marsel Mesulam, M.‐Marsel Mesulam, Howard D. Rees, Nicholas T. Seyfried and Duc M. Duong and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Allan I. Levey

491 papers receiving 51.1k citations

Hit Papers

Central cholinergic pathw... 1983 2026 1997 2011 1983 1983 1994 2005 1996 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
    1983 2.0k citations Allan I. Levey et al. profile →
  2. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey
    1983 1.6k citations Allan I. Levey et al. profile →
  3. Localization of neuronal and glial glutamate transporters
    1994 1.4k citations Allan I. Levey et al. profile →
  4. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
    2005 1.3k citations Allan I. Levey et al. profile →
  5. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
    1996 1.2k citations Allan I. Levey et al. profile →
  6. Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
    1995 1.2k citations Allan I. Levey et al. Annals of Neurology profile →
  7. Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo
    1996 863 citations Allan I. Levey et al. profile →
  8. Distribution of cholinergic neurons in rat brain: Demonstrated by the immunocytochemical localization of choline acetyltransferase
    1983 844 citations Clifford B. Saper, Allan I. Levey et al. profile →
  9. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies
    1991 808 citations Allan I. Levey et al. profile →
  10. 5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging
    2011 638 citations Qing Dai, Marla Gearing et al. profile →
  11. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
    1996 627 citations Allan I. Levey et al. profile →
  12. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine
    2002 549 citations Allan I. Levey et al. profile →
  13. Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
    1997 528 citations Allan I. Levey et al. profile →
  14. AMPA glutamate receptor subunits are differentially distributed in rat brain
    1993 513 citations Allan I. Levey et al. profile →
  15. Evidence for brain glucose dysregulation in Alzheimer's disease
    2017 360 citations Eric B. Dammer, Allan I. Levey et al. Alzheimer s & Dementia profile →
  16. Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms
    2020 297 citations Allan I. Levey et al. Nature Communications profile →
  17. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis
    2021 201 citations Aliza P. Wingo, Yue Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan I. Levey United States 118 26.2k 24.0k 11.8k 8.9k 7.0k 507 52.1k
Kjell Fuxé Sweden 126 52.1k 2.0× 35.8k 1.5× 9.7k 0.8× 9.6k 1.1× 7.5k 1.1× 1.4k 83.2k
Miklós Palkovits Hungary 95 33.4k 1.3× 17.1k 0.7× 9.6k 0.8× 10.9k 1.2× 3.9k 0.6× 692 62.5k
Eric J. Nestler United States 157 47.0k 1.8× 35.6k 1.5× 11.0k 0.9× 15.0k 1.7× 2.8k 0.4× 667 92.0k
Joseph T. Coyle United States 99 25.2k 1.0× 18.9k 0.8× 5.7k 0.5× 7.2k 0.8× 3.5k 0.5× 423 44.5k
Clifford J. Woolf United States 127 23.1k 0.9× 15.3k 0.6× 39.2k 3.3× 5.1k 0.6× 6.7k 1.0× 379 69.4k
Stephen G. Waxman United States 110 22.1k 0.8× 23.7k 1.0× 18.5k 1.6× 3.1k 0.4× 6.4k 0.9× 684 46.5k
Donald L. Price United States 108 16.3k 0.6× 16.9k 0.7× 17.3k 1.5× 4.6k 0.5× 9.8k 1.4× 365 44.1k
Lennart Mucke United States 97 13.4k 0.5× 12.4k 0.5× 20.8k 1.8× 4.0k 0.5× 4.1k 0.6× 172 38.9k
Elliott J. Mufson United States 88 13.7k 0.5× 9.9k 0.4× 10.7k 0.9× 8.1k 0.9× 2.6k 0.4× 301 31.0k
Carl W. Cotman United States 145 33.8k 1.3× 28.1k 1.2× 26.0k 2.2× 11.0k 1.2× 4.2k 0.6× 671 77.5k

Countries citing papers authored by Allan I. Levey

Since Specialization
Citations

This map shows the geographic impact of Allan I. Levey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan I. Levey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan I. Levey more than expected).

Fields of papers citing papers by Allan I. Levey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan I. Levey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan I. Levey. The network helps show where Allan I. Levey may publish in the future.

Co-authorship network of co-authors of Allan I. Levey

This figure shows the co-authorship network connecting the top 25 collaborators of Allan I. Levey. A scholar is included among the top collaborators of Allan I. Levey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan I. Levey. Allan I. Levey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hüls, Anke, Youran Tan, Zhenjiang Li, et al.. (2025). Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach. Alzheimer s & Dementia. 21(9). e70528–e70528.
2.
Carter, Kathleen, Lingyan Ping, Duc M. Duong, et al.. (2025). Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers. Alzheimer s & Dementia. 21(11). e70830–e70830.
3.
Lah, James J., Benjamin B. Risk, John Hanfelt, et al.. (2024). Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African Americans. Annals of Neurology. 96(3). 463–475. 1 indexed citations
4.
Li, Zhenjiang, Donghai Liang, Stefanie Ebelt, et al.. (2024). Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease among a Cognitively Healthy Population-Based Cohort. Environmental Health Perspectives. 132(4). 47001–47001. 15 indexed citations
5.
Li, Zhenjiang, Donghai Liang, Stefanie Ebelt, et al.. (2024). Differential DNA methylation in the brain as potential mediator of the association between traffic‐related PM2.5 and neuropathology markers of Alzheimer's disease. Alzheimer s & Dementia. 20(4). 2538–2551. 19 indexed citations
6.
Wang, Chenxi, et al.. (2024). Brain derived β-interferon is a potential player in Alzheimer’s disease pathogenesis and cognitive impairment. Alzheimer s Research & Therapy. 16(1). 271–271. 1 indexed citations
7.
Kahn, Richard, Harvinder Virk, Carl Laflamme, et al.. (2024). Antibody characterization is critical to enhance reproducibility in biomedical research. eLife. 13. 7 indexed citations
8.
Watson, Caroline M, Eric B. Dammer, Lingyan Ping, et al.. (2023). Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease. Scientific Data. 10(1). 261–261. 21 indexed citations
9.
Klein, Hans‐Ulrich, Lei Yu, Allan I. Levey, et al.. (2023). Proteome-wide Analyses Identified Cortical Proteins Associated With Resilience for Varied Cognitive Abilities. Neurology. 102(1). e207816–e207816. 3 indexed citations
10.
Roberts, Blaine R., Inge M.W. Verberk, Kevin E. Yarasheski, et al.. (2023). Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(4). e12496–e12496. 2 indexed citations
11.
Wingo, Thomas S., Yue Liu, Ekaterina S. Gerasimov, et al.. (2022). Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nature Communications. 13(1). 4314–4314. 94 indexed citations
12.
Morgan, John C., Miranda A. Moore, Theodore M. Johnson, et al.. (2022). The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias. Journal of the American Geriatrics Society. 70(4). 1257–1267. 10 indexed citations
13.
Umoh, Mfon, Eric B. Dammer, Duc M. Duong, et al.. (2017). A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Molecular Medicine. 10(1). 48–62. 100 indexed citations
14.
Bernstein, Alison I., Yunting Lin, Li Lin, et al.. (2016). 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer’s disease modulate Tau-induced neurotoxicity. Human Molecular Genetics. 25(12). ddw109–ddw109. 51 indexed citations
15.
Betarbet, Ranjita, Marla Gearing, Jeffrey R. Gulcher, et al.. (2007). PARK10 Candidate RNF11 Is Expressed by Vulnerable Neurons and Localizes to Lewy Bodies in Parkinson Disease Brain. Journal of Neuropathology & Experimental Neurology. 66(10). 955–964. 26 indexed citations
16.
Dodson, Sara E., James T. Shoemaker, Jason J. Fritz, et al.. (2006). The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments. Journal of Neuroscience Nursing. 26(5). 1596–1603. 22 indexed citations
17.
Zeng, Fanxing, Ronald J. Voll, John R. Votaw, et al.. (2006). Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging β-amyloid in Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 16(11). 3015–3018. 42 indexed citations
18.
Volpicelli, Laura A. & Allan I. Levey. (2004). Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Progress in brain research. 145. 59–66. 235 indexed citations
19.
Levey, Allan I. & Michael Lindenbaum. (2000). Sequential Karhunen-Loeve basis extraction and its application to images. IEEE Transactions on Image Processing. 9(8). 1371–1374. 256 indexed citations
20.
Dörje, Frank, Allan I. Levey, & Mark R. Brann. (1991). Immunological Detection of Muscarinic Receptor Subtype Proteins (m1–m5) in Rabbit Peripheral Tissues. Molecular Pharmacology. 40(4). 459–462. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjell Fuxé Breakdown of academic impact, for papers by Miklós Palkovits Breakdown of academic impact, for papers by Eric J. Nestler Breakdown of academic impact, for papers by Joseph T. Coyle Breakdown of academic impact, for papers by Clifford J. Woolf Breakdown of academic impact, for papers by Stephen G. Waxman Breakdown of academic impact, for papers by Donald L. Price Breakdown of academic impact, for papers by Lennart Mucke Breakdown of academic impact, for papers by Elliott J. Mufson Breakdown of academic impact, for papers by Carl W. Cotman
Rankless by CCL
2026